8.99
Upstream Bio Inc (UPB) 最新ニュース
Jennison Associates LLC Makes New Investment in Upstream Bio, Inc. $UPB - MarketBeat
UPB Stock Price, Quote & Chart | UPSTREAM BIO INC (NASDAQ:UPB) - ChartMill
Upstream Bio down despite mid-stage trial win for asthma drug - MSN
Upstream Bio (UPB) price target decreased by 10.31% to 44.37 - MSN
Upstream Bio lead drug pivotal trial plan follows strong phase 2 data - MSN
UPB Forecast, Price Target & Analyst Ratings | UPSTREAM BIO INC (NASDAQ:UPB) - ChartMill
Segment Overview and Major Growth Areas in the Upstream Bioprocessing Market - openPR.com
Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight - GlobeNewswire Inc.
Upstream Bio, Inc. (NASDAQ:UPB) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Upstream Bio (UPB) Stock Bonus Issue (Bearish Sentiment) 2026-04-20Bullish Pattern - Newser
Upstream Bio (UPB) Stock Ask Wall (Trend Weakens) 2026-04-18Upside Potential - Cổng thông tin điện tử tỉnh Lào Cai
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference - Sahm
Upstream Bio to present verekitug data at medical conference By Investing.com - Investing.com Australia
Upstream Bio to present verekitug data at medical conference - Investing.com
Can Upstream Bio (UPB) Stock Beat Estimates | Price at $10.24, Down 2.38%Hot Momentum - Cổng thông tin điện tử tỉnh Lào Cai
Bull Bear: Is Upstream Bio Inc a cyclical or defensive stock2026 Intraday Action & Low Drawdown Trading Strategies - baoquankhu1.vn
UPB Options Volatility — NASDAQ:UPB - TradingView — Track All Markets
UPB Options Chain — NASDAQ:UPB - TradingView
Validating the IL-13/TSLP Axis: Upstream Bio’s Verekitug Positioned for Differentiated Asthma Efficacy and Favorable Risk–Reward - TipRanks
Earnings Update: Is Upstream Bio Inc still a buy after recent gains2026 Rallies & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (UPB) and Pfizer (PFE) - The Globe and Mail
Truist cuts Upstream Bio stock price target on trial timeline By Investing.com - Investing.com Canada
Market Recap: Is Upstream Bio Inc forming a bullish divergence2026 Volume & Daily Chart Pattern Signals - baoquankhu1.vn
Piper Sandler Maintains UpStream Bio(UPB.US) With Buy Rating, Maintains Target Price $75 - Moomoo
Upstream Bio, Inc. (UPB) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Retail Surge: Does Upstream Bio Inc have a sustainable dividendTrade Signal Summary & Verified Trade Idea Suggestions - baoquankhu1.vn
UpStream Bio | 10-K: FY2025 Annual Report - Moomoo
Upstream Bio, Inc. (NASDAQ:UPB) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Upstream Bio (NASDAQ:UPB) Rating Lowered to Sell at Wall Street Zen - MarketBeat
VALIANT Asthma Trial Update: What Upstream Bio’s Phase 2 Milestone Means for Investors - TipRanks
Upstream Bio (NASDAQ:UPB) Downgraded by Evercore to In-Line - MarketBeat
A Quick Look at Today's Ratings for UpStream Bio(UPB.US), With a Forecast Between $15 to $42 - moomoo.com
大文字化:
|
ボリューム (24 時間):